Left Supraclavicular Lymph Node Metastasis from Ovarian Cancer Associated with Papillary Thyroid Microcarcinoma, a Confusing Pathology-Essential Role of Functional Imaging.

18F-fludeoxyglucose positron emission tomography-computed tomography ovarian carcinoma papillary thyroid microcarcinoma supraclavicular metastasis

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
30 Apr 2020
Historique:
received: 02 04 2020
revised: 15 04 2020
accepted: 29 04 2020
entrez: 6 5 2020
pubmed: 6 5 2020
medline: 6 5 2020
Statut: epublish

Résumé

The revolution of imaging in medicine leads to new standards of care, mostly in specialties like oncology, neurology, or endocrinology. We present a review of the literature and a case report of a 62-year-old patient initially treated for a benign gynecologic pathology and followed-up for 7 years clinically, with serologic and with multiple imaging techniques. There is an actual growing use of highly sensitive functional imaging methods, like fluoro-deoxy-glucose (F18-FDG) positron emission tomography/computed tomography (PET/CT) in the evaluation of oncologic pathologies, staging, follow-up, and therapy response monitoring. This is the first case report described in the literature presenting the association of thyroid papillary microcarcinoma (MPTC) and supraclavicular metastasis of ovarian cancer. The study aims to underline the necessity of a complex and careful evaluation of each oncologic patient, due to the unexpected clinical presentation and rare association of diseases, sometimes leading to confusing management.

Identifiants

pubmed: 32365823
pii: diagnostics10050270
doi: 10.3390/diagnostics10050270
pmc: PMC7277915
pii:
doi:

Types de publication

Case Reports

Langues

eng

Références

Am J Surg Pathol. 2004 Sep;28(9):1217-23
pubmed: 15316322
Taiwan J Obstet Gynecol. 2011 Mar;50(1):98-9
pubmed: 21482383
Cancer. 2006 Apr 1;106(7):1624-33
pubmed: 16518827
Am J Surg Pathol. 2012 Jul;36(7):955-63
pubmed: 22613998
J Med Case Rep. 2012 Jul 02;6:176
pubmed: 22747642
CA Cancer J Clin. 2018 Jul;68(4):284-296
pubmed: 29809280
Eur Thyroid J. 2019 Oct;8(5):227-245
pubmed: 31768334
Int J Gynecol Cancer. 2013 Feb;23(2):268-75
pubmed: 23358178
Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):404-13
pubmed: 26381775
Cancer Imaging. 2006 Mar 23;6:20-3
pubmed: 16581520
J Gynecol Oncol. 2013 Oct;24(4):352-8
pubmed: 24167671
Thyroid. 2017 Nov;27(11):1341-1346
pubmed: 29091573
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Int J Cancer. 2017 Jun 1;140(11):2451-2460
pubmed: 28257597
Clin Nucl Med. 2012 Feb;37(2):214-5
pubmed: 22228358
Chirurgia (Bucur). 2013 Jul-Aug;108(4):490-7
pubmed: 23958091
Rare Tumors. 2012 Apr 12;4(2):e26
pubmed: 22826783
J Am Coll Radiol. 2015 Dec;12(12 Pt A):1272-9
pubmed: 26419308
Am J Clin Oncol. 2000 Aug;23(4):416-9
pubmed: 10955875
J Obstet Gynaecol. 2005 Jul;25(5):528-9
pubmed: 16261694
Surg Oncol. 2014 Mar;23(1):40-4
pubmed: 24183480
Gynecol Oncol. 2007 Jan;104(1):41-5
pubmed: 16952391
Arch Gynecol Obstet. 2011 Sep;284(3):743-7
pubmed: 21706344
Clujul Med. 2017;90(2):147-153
pubmed: 28559697
Ann Surg Oncol. 2004 Jul;11(7):658-64
pubmed: 15197013
Acta Endocrinol (Buchar). 2019 Apr-Jun;15(2):203-208
pubmed: 31508177
Cancer Genomics Proteomics. 2016 11-12;13(6):407-423
pubmed: 27807064
Oncotarget. 2018 Jun 26;9(49):29275-29283
pubmed: 30018751
Nucl Med Commun. 2007 Aug;28(8):589-95
pubmed: 17625380
Diagnostics (Basel). 2019 Aug 07;9(3):
pubmed: 31394887
J Gynecol Oncol. 2018 May;29(3):e37
pubmed: 29533021
Eur J Radiol. 2009 Jul;71(1):164-74
pubmed: 18378417
Methods Mol Biol. 2011;727:171-89
pubmed: 21331934
Cochrane Database Syst Rev. 2015 Aug 12;(8):CD003677
pubmed: 26264829
Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1259-69
pubmed: 20309683
Trials. 2017 Nov 25;18(1):565
pubmed: 29178955
Arch Gynecol Obstet. 2007 May;275(5):389-91
pubmed: 17177031
Oncol Lett. 2018 Jul;16(1):505-510
pubmed: 29928439

Auteurs

Doina Piciu (D)

Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Department of Endocrine Tumors and Nuclear Medicine, "Prof. Dr. I. Chiricuță" Institute of Oncology, 400015 Cluj-Napoca, Romania.

Alexandru Meșter (A)

Department of Oral Health, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Calin Căinap (C)

Department of Medical Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Elena Bărbuș (E)

Department of Endocrine Tumors and Nuclear Medicine, "Prof. Dr. I. Chiricuță" Institute of Oncology, 400015 Cluj-Napoca, Romania.

Dragos-Stefan Morariu (DS)

Department of Surgical Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Andra Piciu (A)

Department of Medical Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Classifications MeSH